Waystar to Announce Second Quarter 2025 Financial Results on July 30, 2025

LEHI, Utah, and LOUISVILLE, Ky., July 9, 2025 /PRNewswire/ — Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, announced today that it will report financial results for the second quarter ended June 30, 2025, after market…

VSA Regains Compliance with Nasdaq Minimum Bid Price Requirement

BEIJING, July 9, 2025 /PRNewswire/ — TCTM Kids IT Education Inc. (NASDAQ: VSA) (“VSA” or the “Company”), an emerging technology services company, specializing in biomedical applications, research & development, and online education, today announced that it has received a written…

AGCO Announces New $1 Billion Share Repurchase Program

DULUTH, Ga., July 9, 2025 /PRNewswire/ — AGCO (NYSE: AGCO), a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology, today announced its Board of Directors has authorized a new share repurchase program of…

Taiho Oncology and Taiho Pharmaceutical Announce U.S. FDA Acceptance of Supplemental New Drug Application for INQOVI® in Combination with Venetoclax to Treat Patients with Acute Myeloid Leukemia

The submission is based on clinical trial data demonstrating that INQOVI in combination with venetoclax met complete response endpoints; no new safety concerns were reportedIf approved, INQOVI in combination with venetoclax would be the first all-oral combination treatment for patients…